EMFACE vs Ultherapy

Independent side-by-side comparison with pricing, specs, and clinical evidence.

Last updated: 2026-04-09

Why This Comparison Matters

EMFACE and Ultherapy sit in the same facial aesthetics category but take different approaches. EMFACE (BTL Industries) uses Synchronized RF + HIFES (High-Intensity Facial Electrical Stimulation) while Ultherapy (Merz Aesthetics) uses Microfocused Ultrasound with Visualization (MFU-V). Both received FDA clearance (2022 and 2009 respectively) and both are actively sold in the US market. The decision between them is rarely about which is objectively better. It's about which fits your specific practice.

Physicians end up comparing these two devices when they're shopping in the $90,000-$125,000 to $70,000-$120,000 price range and want a category leader. Both devices are commonly recommended by sales reps from competing manufacturers, which means physicians often hear inflated claims about one and dismissive claims about the other. This comparison strips out the marketing and looks at pricing, mechanism, evidence, and practice fit side by side.

Side-by-Side Specifications

EMFACE Ultherapy
Manufacturer BTL Industries Merz Aesthetics
Technology Synchronized RF + HIFES (High-Intensity Facial Electrical Stimulation) Microfocused Ultrasound with Visualization (MFU-V)
Price (New) $90,000-$125,000 $70,000-$120,000
Price (Used) $50,000-$85,000 $30,000-$60,000
Treatment Time 20 minutes 30-90 minutes
Sessions 4 sessions weekly 1 session, maintenance every 12-18 months
Per Session $1,200-$2,500 $1,800-$5,000
Annual Consumables $2,500-$6,000 (single-use applicator pads) $15,000-$35,000 (transducers)
Annual Maintenance $4,000-$8,000 $4,000-$9,000
FDA Cleared Yes (2022) Yes (2009)

Technology

EMFACE

Technology: Synchronized RF + HIFES (High-Intensity Facial Electrical Stimulation). First device to simultaneously stimulate facial muscles (HIFES) while heating skin with RF. Marketed as a non-injectable alternative to Botox and filler for brow and midface lifting.

Ultherapy

Technology: Microfocused Ultrasound with Visualization (MFU-V). The only non-invasive lifting device cleared to target the SMAS layer that surgeons target in facelift surgery. Integrated imaging lets the operator see each treatment layer before delivering energy.

Pricing

EMFACE

New: $90,000-$125,000. Used: $50,000-$85,000. Per session: $1,200-$2,500. Annual consumables: $2,500-$6,000 (single-use applicator pads). Annual maintenance: $4,000-$8,000.

Ultherapy

New: $70,000-$120,000. Used: $30,000-$60,000. Per session: $1,800-$5,000. Annual consumables: $15,000-$35,000 (transducers). Annual maintenance: $4,000-$9,000.

Clinical Evidence

EMFACE

Growing peer-reviewed base since 2022 clearance. Studies show measurable improvement in muscle tone and skin laxity metrics at 3 months.

Ultherapy

80+ published studies. Strongest non-invasive lifting evidence base. Meta-analyses confirm measurable improvement in brow and submental laxity.

Treatment Experience

EMFACE

20 minutes per session. Recommended protocol: 4 sessions weekly. Treatment areas: Forehead, Cheeks (lifts brows and cheeks). Patients typically tolerate this platform well when operated by trained clinicians.

Ultherapy

30-90 minutes per session. Recommended protocol: 1 session, maintenance every 12-18 months. Treatment areas: Brow, Submental (chin), Neck, Decolletage. Patient experience varies by operator training and settings.

Practice Fit

EMFACE

Med spas and plastic surgery practices wanting a non-injectable revenue line to complement or replace filler and neurotoxin offerings. BTL ecosystem practices building multi-device packages.

Ultherapy

Dermatology and plastic surgery practices that serve patients declining surgery but wanting measurable lift. Premium med spas with established demand for single-session skin tightening.

Pros and Cons

EMFACE Pros

  • Created a new non-injectable facial category
  • Strong patient demand for needle-free alternatives
  • 20-minute hands-free treatment lets operators multi-task
  • Pairs with BTL body contouring and pelvic health platforms for cross-sell

EMFACE Cons

  • Single-use applicator pads add meaningful consumable cost
  • Results are more subtle than injectables in many patients
  • Clinical evidence is growing but base is still thin

Ultherapy Pros

  • Reaches the SMAS layer non-invasively (unique capability)
  • Integrated ultrasound imaging improves targeting accuracy
  • Strongest lifting claims among non-invasive devices
  • Long safety record (cleared since 2009)

Ultherapy Cons

  • Treatment can be painful and usually requires pre-medication
  • Transducer consumables are expensive and area-specific
  • Results develop gradually over 2-6 months

The Verdict

Choose EMFACE if your practice prioritizes BTL Industries's ecosystem, brand recognition, or specific clinical advantages. Med spas and plastic surgery practices wanting a non-injectable revenue line to complement or replace filler and neurotoxin offerings. BTL ecosystem practices building multi-device packages. The pros that matter most: Created a new non-injectable facial category; Strong patient demand for needle-free alternatives. The biggest tradeoff to accept: Single-use applicator pads add meaningful consumable cost.

Choose Ultherapy if Merz Aesthetics's positioning fits better. Dermatology and plastic surgery practices that serve patients declining surgery but wanting measurable lift. Premium med spas with established demand for single-session skin tightening. The pros that matter most: Reaches the SMAS layer non-invasively (unique capability); Integrated ultrasound imaging improves targeting accuracy. The biggest tradeoff to accept: Treatment can be painful and usually requires pre-medication.

For a practice with limited capital that needs maximum flexibility, used pricing tilts the math. EMFACE used units run $50,000-$85,000; Ultherapy used units run $30,000-$60,000. For practices with strong patient flow already, the device that integrates with your existing platforms is usually the right answer even if its standalone specs are slightly weaker. For practices building a category from scratch, brand recognition and patient demand matter more than raw clinical specs. Look at which device patients are already asking for in your market before signing a contract.

Frequently Asked Questions

Which is more expensive, EMFACE or Ultherapy?

EMFACE runs $90,000-$125,000 new and $50,000-$85,000 used. Ultherapy runs $70,000-$120,000 new and $30,000-$60,000 used. Per-session pricing is $1,200-$2,500 for EMFACE and $1,800-$5,000 for Ultherapy. Annual operating costs (consumables plus maintenance) typically run 5-15% of purchase price for both devices. The right financial comparison includes total cost of ownership over 5 years, not just sticker price.

Which has better clinical evidence, EMFACE or Ultherapy?

EMFACE clinical evidence: Growing peer-reviewed base since 2022 clearance. Studies show measurable improvement in muscle tone and skin laxity metrics at 3 months. Ultherapy clinical evidence: 80+ published studies. Strongest non-invasive lifting evidence base. Meta-analyses confirm measurable improvement in brow and submental laxity. Evidence quality is not about study count alone. Look at sample sizes, blinded evaluators, independence from manufacturer funding, and outcome durability. Older devices in the same category usually have stronger evidence because they've been studied longer.

Is EMFACE or Ultherapy more popular in dermatology practices?

Both EMFACE and Ultherapy are commonly used in dermatology, plastic surgery, med spa practices. Market share in any given category shifts year to year. BTL Industries and Merz Aesthetics both maintain active sales forces in the US. Ask other physicians in your specialty which platform they're using and why. Peer references in your local market matter more than national market share data.

Are there safety concerns with EMFACE or Ultherapy?

Both devices are FDA cleared and have established safety profiles. EMFACE has these documented concerns: Single-use applicator pads add meaningful consumable cost. Ultherapy has: Treatment can be painful and usually requires pre-medication. Physicians should monitor FDA MAUDE reports for both devices before purchase. Adverse event trends matter because they signal problems that may not appear in marketing materials. Any device with a sudden spike in MAUDE filings deserves closer scrutiny.

Can I use EMFACE and Ultherapy in the same practice?

Some practices run both devices, especially when they target different patient segments or treatment areas. The downside is duplicated training, parallel consumable inventories, and potential cannibalization between platforms. The upside is broader marketing claims and the ability to switch patients between platforms if one doesn't deliver expected results. Most practices choose one and commit to mastering it rather than splitting volume.

What's the resale value comparison between EMFACE and Ultherapy?

Used EMFACE sells for $50,000-$85,000 on the secondary market. Used Ultherapy sells for $30,000-$60,000. Resale values depend on age, software version, applicator condition, and remaining warranty. Devices with strong installed bases hold value better. Devices with active safety signals or declining manufacturer financial health depreciate faster. Resale value should be a factor in any device purchase, especially if practice plans might change in 3-5 years.